A randomized controlled trial of a low-dose combined oral contraceptive containing 3 mg drospirenone plus 20 microg ethinylestradiol in the treatment of acne vulgaris: lesion counts, investigator ratings and subject self-assessment. - Concepedia

Concepedia

Publication | Closed Access

A randomized controlled trial of a low-dose combined oral contraceptive containing 3 mg drospirenone plus 20 microg ethinylestradiol in the treatment of acne vulgaris: lesion counts, investigator ratings and subject self-assessment.

17

Citations

0

References

2009

Year

J Michael Maloney, Peter Dietze, David I. Watson, Minoo Niknian, Sooji Lee-Rugh, Carole Sampson-Landers, Paul Körner

Abstract

The 3 mg drsp/20 microg EE COC administered in a 24/4 regimen significantly reduced acne lesions.